UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 522

Sortiert nach

Development of a cell-free screening assay for the identification of direct PERK activators

PloS one, 2023-05, Vol.18 (5), p.e0283943-e0283943

2023

Volltextzugriff (PDF)

PERK activation mitigates tau pathology in vitro and in vivo

EMBO molecular medicine, 2017-03, Vol.9 (3), p.371-384

2017

Volltextzugriff (PDF)

Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT

Blood, 2023-03, Vol.141 (13), p.1626-1639

2023

Volltextzugriff (PDF)

Systemically administered neuregulin‐1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease

Journal of neurochemistry, 2015-05, Vol.133 (4), p.590-597

2015

Volltextzugriff (PDF)

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

Leukemia, 2017-06, Vol.31 (6), p.1463-1466

2017

Volltextzugriff (PDF)

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue

Acta neuropathologica communications, 2023-03, Vol.11 (1), p.40-40, Article 40

2023

Volltextzugriff (PDF)

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

Leukemia, 2015-05, Vol.29 (5), p.1060-1068

2015

Volltextzugriff (PDF)

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

Leukemia, 2016-02, Vol.30 (2), p.261-267

2016

Volltextzugriff (PDF)

Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease

Journal of neurochemistry, 2011-06, Vol.117 (6), p.1066-1074

2011

Volltextzugriff (PDF)

Four-repeat tauopathies

Progress in neurobiology, 2019-09, Vol.180, p.101644, Article 101644

2019

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

Annals of oncology, 2017-11, Vol.28 (11), p.2793-2798

2017

Volltextzugriff (PDF)

Comprehensive miRNome-Wide Profiling in a Neuronal Cell Model of Synucleinopathy Implies Involvement of Cell Cycle Genes

Frontiers in cell and developmental biology, 2021-03, Vol.9, p.561086-561086

2021

Volltextzugriff (PDF)

Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy

Cell death & disease, 2018-07, Vol.9 (7), p.757-14, Article 757

2018

Volltextzugriff (PDF)

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

Bone marrow transplantation (Basingstoke), 2011-08, Vol.46 (8), p.1045-1052

2011

Volltextzugriff (PDF)

Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma

Leukemia, 2017-08, Vol.31 (8), p.1816-1819

2017

Volltextzugriff (PDF)

Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

Neurology, 2019-07, Vol.93 (2), p.e135

2019

Volltextzugriff (PDF)

Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1

Neuropharmacology, 2011-12, Vol.61 (8), p.1413-1418

2011

Volltextzugriff (PDF)

Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers

PloS one, 2014-07, Vol.9 (7), p.e102397

2014

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative forFLT3-ITD,NPM1- or biallelicCEBPA mutations

Annals of oncology, 2017-11, Vol.28 (11), p.2793-2798

2017

Volltextzugriff (PDF)

Current developments in cancer care: including the patients’ perspective—3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany

Journal of Cancer Research & Clinical Oncology, 2017-04, Vol.143 (4), p.673-676

2017

Volltextzugriff (PDF)

Multiple molecular pathways stimulating macroautophagy protect from alpha-synuclein-induced toxicity in human neurons

Neuropharmacology, 2019-05, Vol.149, p.13-26

2019

Volltextzugriff (PDF)

Tau links developmental to neurodegenerative diseases

Neuroscience and biobehavioral reviews, 2019-09, Vol.104, p.26-27

2019

Volltextzugriff (PDF)

Disease-modifying strategies in primary tauopathies

Neuropharmacology, 2020-05, Vol.167, p.107842-107842, Article 107842

2020

Volltextzugriff (PDF)

Primary parotid gland lymphoma: pitfalls in the use of ultrasound imaging by a great pretender

International journal of oral and maxillofacial surgery, 2021-05, Vol.50 (5), p.573-578

2021

Volltextzugriff (PDF)

1 – 25 von 522

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(374)
Mit Volltextzugriff
(417)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of a cell-free screening assay for the identification of direct PERK activators

PERK activation mitigates tau pathology in vitro and in vivo

Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT

Systemically administered neuregulin‐1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma

Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

Systemic administration of neuregulin‐1β1 protects dopaminergic neurons in a mouse model of Parkinson’s disease

Four-repeat tauopathies

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations

Comprehensive miRNome-Wide Profiling in a Neuronal Cell Model of Synucleinopathy Implies Involvement of Cell Cycle Genes

Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma

Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1

Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative forFLT3-ITD,NPM1- or biallelicCEBPA mutations

Current developments in cancer care: including the patients’ perspective—3rd European Roundtable Meeting (ERTM) June 17, 2016, Berlin, Germany

Multiple molecular pathways stimulating macroautophagy protect from alpha-synuclein-induced toxicity in human neurons

Tau links developmental to neurodegenerative diseases

Disease-modifying strategies in primary tauopathies

Primary parotid gland lymphoma: pitfalls in the use of ultrasound imaging by a great pretender

Suchergebnisse filtern